byproduct.4d Although the naturally occurring dibenz[b,f]oxepin
derivatives were only found in the closely related family of the
cularine alkaloids,6 many natural products containing the
skeleton were recently isolated from the rootbarks of Artocarpus
rigida,7 Bauhinia saccocalyx,8 and Cercis chinensis.9 Some of
them exhibit excellent biological and pharmaceutical activities,10
and their derivatives are widely used in industry.11 The general
strategy for the synthesis of dibenz[b,f]oxepin was mainly
ascribed to two pathways involving the intramolecular C-O
ether bond formation of 2-styrylphenols and the cyclodehydra-
tion of preformed diaryl ether intermediates.6 However, both
methods are conducted under harsh conditions and also include
a multistep reaction process. Xanthene seems to be desirable
as a readily available starting material since it only differs in a
single carbon atom from dibenz[b,f]oxepin.12 Therefore, we
focused on the dibenz[b,f]oxepin isolated from the oxidation
of xanthene in the presence of dimethyl malonate4d because the
mechanism for the formation of the dibenz[b,f]oxepin as well
as the skeleton was quite interesting to us. The dibenz[b,f]oxepin
would probably be formed by the ring-expansion including the
Synthesis of Dibenz[b,f]oxepins via
Manganese(III)-Based Oxidative 1,2-Radical
Rearrangement
Zhiqi Cong, Takumi Miki, Osamu Urakawa, and
Hiroshi Nishino*
Department of Chemistry, Graduate School of Science and
Technology, Kumamoto UniVersity, Kurokami 2-39-1,
Kumamoto 860-8555, Japan
ReceiVed February 11, 2009
(3) (a) Asahi, K.; Nishino, H. Tetrahedron 2008, 64, 1620–1634. (b) Asahi,
K.; Nishino, H. Eur. J. Org. Chem. 2008, 240, 4–2416. (c) Asahi, K.; Nishino,
H. Tetrahedron Lett. 2006, 47, 7259–7263. (d) Asahi, K.; Nishino, H.
Tetrahedron 2005, 61, 11107–11124. (e) Fujino, R.; Nishino, H. Synthesis 2005,
731, 740. (f) Kumabe, R.; Nishino, H. Heterocycl. Commun. 2004, 10, 135–
138. (g) Kumabe, R.; Nishino, H. Tetrahedron Lett. 2004, 45, 703–706. (h)
Rahman, M. T.; Nishino, H. Tetrahedron 2003, 59, 8383–8392. (i) Rahman,
M. T.; Nishino, H. Org. Lett. 2003, 5, 2887–2890. (j) Rahman, M. T.; Nishino,
H.; Qian, C.-Y. Tetrahedron Lett. 2003, 44, 5225–5228. (k) Jogo, S.; Nishino,
H.; Yasutake, M.; Shinmyozu, T. Tetrahedron Lett. 2002, 43, 9031–9034. (l)
Kumabe, R.; Nishino, H.; Yasutake, M.; Nguyen, V.-H.; Kurosawa, K Tetra-
hedron Lett. 2001, 42, 69–72.
(4) (a) Nishino, H. Bull. Chem. Soc. Jpn. 1986, 59, 1733–1739. (b) Nishino,
H.; Tsunoda, K.; Kurosawa, K. Bull. Chem. Soc. Jpn. 1989, 62, 545–550. (c)
Tsunoda, K.; Yamane, M.; Nishino, H.; Kurosawa, K. Bull. Chem. Soc. Jpn.
1991, 64, 851–856. (d) Nishino, H.; Kamachi, H.; Baba, H; Kurosawa, K. J.
Org. Chem. 1992, 57, 3551–3557. (e) Cong, Z.-Q.; Nishino, H. Synthesis 2008,
2686, 2694.
The oxidation of monoalkyl 2-(9H-xanthenyl)malonates 1
with Mn(OAc)3 gave the 9- or 10-dibenz[b,f]oxepincarboxy-
lates 2 in good yields. The reaction proceeds with high
regioselectivity except for the case of (1-methoxyxanthe-
nyl)malonate 1 (R1 ) Me, R2 ) 1-MeO), which gave two
regioisomers. It was proposed that the process for the
formation of 2 must include the 1,2-aryl radical rearrange-
ment followed by oxidative decarboxylation.
Manganese(III) acetate, Mn(OAc)3, is a versatile reagent for
the C-C bond formation in organic synthesis.1-3 In recent years,
we4 and other groups5 have developed various Mn(III)-based
oxidations of aromatic compounds in the presence of active
methylene species. We previously reported that the oxidation
of xanthene in the presence of dimethyl malonate mainly
produced 2-(9-xanthenyl)malonate (65%) together with a small
(5) (a) Citterio, A.; Santi, R.; Fiorani, T.; Strologo, S. J. Org. Chem. 1989,
54, 2703–2712. (b) Citterio, A.; Fancelli, D.; Finzi, C.; Pesce, L.; Santi, R. J.
Org. Chem. 1989, 54, 2713–2718. (c) Citterio, A.; Sebastiano, R.; Marion, A.;
Santi, R. J. Org. Chem. 1991, 56, 5328–5335. (d) Baciocchi, E.; Muraglia, E. J.
Org. Chem. 1993, 58, 7610–7612. (e) Jiang, M.-C.; Chuang, C.-P. J. Org. Chem.
2000, 65, 5409–5412. (f) Wu, Y.-L; Chuang, C.-P.; Lin, P.-Y. Tetrahedron 2001,
57, 5543–5549. (g) Tsai, A.-I.; Wu, Y.-L.; Chuang, C.-P. Tetrahedron 2001,
57, 7829–7837. (h) Im, Y. J.; Lee, K. Y.; Kim, T. H.; Kim, J. N. Tetrahedron
Lett. 2002, 43, 4675–4678.
(6) For review, see: Olivera, R.; SanMartin, R.; Churruca, F.; Dom´ınguez,
E. Org. Prep. Proc. Int. 2004, 36, 297–330, and references cited therein.
(7) (a) Ko, H.-H.; Yang, S.-Z.; Lin, C.-N. Tetrahedron. Lett. 2001, 5269,
5270. (b) Lu, Y.-H.; Lin, C.-N.; Ko, H.-H.; Yang, S.-Z.; Tsao, L.-T.; Wang,
J.-P. HelV. Chem. Acta 2003, 86, 2566–2572. (c) Paduraru, M. P.; Wilson, P. D.
Org. Lett. 2003, 5, 4911–4913.
(8) (a) Kittakoop, P.; Nopichai, S.; Thongon, N.; Charoenchai, P.; Thebt-
aranonth, Y. HelV. Chem. Acta 2004, 87, 175–179. (b) Pettit, G. R.; Numata,
A.; Iwamoto, C.; Usami, Y.; Yamada, T.; Ohishi, H.; Cragg, G. M. J. Nat, Prod.
2006, 69, 323–327.
(9) Mu, L.-H.; Li, J.-B.; Yang, J.-Z.; Zhang, D.-M. J. Asian Nat. Prod. Res.
2007, 9, 649–653.
(10) (a) Trabanco, A. A.; Alonso, J. M.; Andre´s, J. I.; Cid, J. M.; Ferna´ndez,
J.; Iturrino, L.; Megens, A. Chem. Pharm. Bull. 2004, 52, 262–265. (b) Ferna´ndez,
J.; Alonso, J. M.; Andre´s, J. I.; Cid, J. M.; D´ıaz, A.; Iturrino, L.; Gil, P.; Megens,
A.; Sipido, V. K.; Trabanco, A. A. J. Med. Chem. 2005, 48, 1709–1712. (c)
Trabanco, A. A.; Alonso, J. M.; Cid, J. M.; Font, L. M.; Megens, A. Il Farm.
2005, 60, 241–248. (d) Zimmermann, K.; Waldmeier, P. C.; Tatton, W. G. Pure
Appl. Chem. 1999, 71, 2039–2046. (e) Waldmeier, P. C.; Boulton, A. A.; Cools,
A. R.; Kato, A. C.; Tatton, W. G. AdV. Res. Neurodegen. 2000, 8, 197–214.
(11) (a) Cloos, P. A. C.; Jensen F. R.; Boissy, P.; Stahlhut, M. PCT Int.
Appl. 2004, 61, WO 2004039773; Chem. Abstr., 2004, 140, 406751. (b) Lambrou,
G. N.; Latour, E.; Waldmeier, P. PCT Int. Appl. 2004, 27, WO 2004066993;
Chem. Abstr. 2004, 141, 167848.
amount of 9-dibenz[b,f]oxepincarboxylate (11%) as
a
(1) For review, see: (a) Demir, A. S.; Emrullahoglu, M. Curr. Org. Synth.
2007, 4, 321–351. (b) Nishino, H. In BioactiVe Heterocycles I; Eguchi, S., Eds.;
Springer: Berlin, 2006; pp 39-76. (c) Melikyan, G. G. Aldrichim. Acta 1998,
31, 50–98. (d) Melikyan, G. G. Org. React. 1997, 49, 427–675. (e) Snider, B. B.
Chem. ReV. 1996, 96, 339–363. (f) Iqbal, J.; Bhatia, B.; Nayyar, N. K. Chem.
ReV. 1994, 94, 519–564.
(2) (a) Wang, Y.-F.; Toh, K. K.; Chiba, S.; Narasaka, K. Org. Lett. 2008,
10, 5019–5022. (b) Wang, G.-W.; Dong, Y.-W.; Wu, P.; Yuan, T.-T.; Shen,
Y.-B. J. Org. Chem. 2008, 73, 7088–7095. (c) Powell, L. H.; Docherty, P. H.;
Hulcoopa, D. G.; Kemmitt, P. D.; Burton, J. W. Chem. Commun. 2008, 2559,
2561. (d) Demir, A. S.; Findik, H. Tetrahedron 2008, 64, 6196–6201. (e) Shu,
C.; Cai, T; Xu, L.; Zuo, T; Reid, J; Harich, K; Dorn, H. C; Gibson, H. W.
J. Am. Chem. Soc. 2007, 129, 15710–15717. (f) Chuang, C.-P.; Tsai, A.-I.
Tetrahedron 2007, 63, 11911–11919. (g) Elkaim, L; Grimaud, L.; Vieu, E. Org.
Lett. 2007, 9, 4171–4173. (h) Chuang, C.-P.; Tsai, A.-I. Tetrahedron 2007, 63,
9712–9717. (i) Shanmugam, P.; Kumar, K. H.; Perumal, P. T. J. Heterocycl.
Chem. 2007, 44, 827–830. (j) Burgaz, E. V.; Yilmaz, M.; Pekel, A. T.; Oektemer,
A. Tetrahedron 2007, 63, 7229–7239. (k) Wu, Z.; Huang, X. Synthesis 2007,
45, 50. (l) Fu, W.-J.; Huang, X. J. Organomet. Chem. 2007, 692, 740–745. (m)
C¸ aliskan, R.; Ali, M. F.; Sahin, E.; Watson, W. H.; Balci, M. J. Org. Chem.
2007, 72, 3353–3359.
3978 J. Org. Chem. 2009, 74, 3978–3981
10.1021/jo9002773 CCC: $40.75 2009 American Chemical Society
Published on Web 04/22/2009